Should we be evaluating blood involvement in early-stage paediatric mycosis fungoides? A retrospective cohort analysis using flow cytometry
Clinical and Experimental Dermatology · 2025
DOI: 10.1093/ced/llaf340 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2025. Verfasst von Yael Renert-Yuval und 7 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 11 Literaturangaben.
Abstract (Originalsprache)
Flow cytometry is a standard tool for blood involvement classification in mycosis fungoides (MF). However, data are lacking for paediatric patients, who primarily exhibit early-stage disease. We retrospectively analysed flow cytometry results from 65 paediatric patients with early-stage MF. All were classified as B0 or B1, indicating no or low-level blood involvement, respectively. None met the B2 criteria. B1 rates were 34% and 49%, based on percentage and absolute count criteria of CD4+/CD7– or CD4+/CD26–, respectively. These rates are markedly higher than previously reported for adult MF. B status was not correlated with demographic or clinical findings. During a mean (SD) follow-up of 5.6 (4.0) years, none of the patients had stage progression. Our cohort’s frequent B1 classification in early-stage paediatric MF suggests that a reassessment of the criteria defining B0 and B1 may be necessary. Furthermore, considering the benign course of paediatric MF, the clinical significance of B status assessment warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Paediatric Dermatology Unit, Schneider Children's Medical Center of Israel, Petah Tikva, Israel.
- Gary Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Division of Dermatology, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel.
- Hematology Laboratory, Beilinson Hospital, Rabin Medical Center, Petah Tikva, Israel.
- Division of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Hospital.
ORCID-Profile: Yael Renert-Yuval, Rivka Friedland
Zitieren
APA
Renert-Yuval, Y., Prag Naveh, H., Reiter, O., Shahal-Zimra, Y., Pickholtz, I., Ben Amitai, D., Friedland, R., & Hodak, E. (2025). Should we be evaluating blood involvement in early-stage paediatric mycosis fungoides? A retrospective cohort analysis using flow cytometry. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llaf340
Vancouver
Renert-Yuval Y, Prag Naveh H, Reiter O, Shahal-Zimra Y, Pickholtz I, Ben Amitai D, et al. Should we be evaluating blood involvement in early-stage paediatric mycosis fungoides? A retrospective cohort analysis using flow cytometry. Clinical and Experimental Dermatology. 2025. doi:10.1093/ced/llaf340
BibTeX
@article{RenertYuval2025,
author = {Renert-Yuval, Yael and Prag Naveh, Hadas and Reiter, Ofer and Shahal-Zimra, Yael and Pickholtz, Itay and Ben Amitai, Dan and Friedland, Rivka and Hodak, Emmilia},
title = {Should we be evaluating blood involvement in early-stage paediatric mycosis fungoides? A retrospective cohort analysis using flow cytometry},
journal = {Clinical and Experimental Dermatology},
year = {2025},
doi = {10.1093/ced/llaf340}
}
EUVIMED